Enzyme-linked immunosorbent assay of carbamoylphosphate synthetase I: plasma enzyme in rat experimental hepatitis and its clearance.

Enzyme & protein Pub Date : 1994-01-01 DOI:10.1159/000474991
M Ozaki, K Terada, M Kanazawa, S Fujiyama, K Tomita, M Mori
{"title":"Enzyme-linked immunosorbent assay of carbamoylphosphate synthetase I: plasma enzyme in rat experimental hepatitis and its clearance.","authors":"M Ozaki,&nbsp;K Terada,&nbsp;M Kanazawa,&nbsp;S Fujiyama,&nbsp;K Tomita,&nbsp;M Mori","doi":"10.1159/000474991","DOIUrl":null,"url":null,"abstract":"<p><p>Carbamoylphosphate synthetase I (CPS I), a urea cycle enzyme, is located almost exclusively in the mitochondria of hepatocytes. The enzyme is unique in that it constitutes about 2-6% of total liver protein and is composed of a large subunit of 160 kD. We developed a sensitive enzyme-linked immunosorbent assay (ELISA) for measurement of the enzyme in plasma using an antibody against the rat enzyme. In galactosamine-induced rat acute hepatitis, plasma concentration of CPS I that was 1-2 micrograms/ml blood before the treatment, increased up to 125 micrograms/ml blood in 24 h after the treatment and decreased to a near control level in 72 h. Plasma concentration of ornithine carbamoyl-transferase (OCT), another urea cycle enzyme, reached a maximum in 24 h and then decreased a little more rapidly than that of CPS I. On the other hand, alanine aminotransferase activity reached a maximum in 36 h and decreased to a normal level in 96 h. In immunoblot analysis, the native CPS I polypeptide of 160 kD and its fragments of 140 and 125 kD were detected 24-48 h after the treatment. When purified rat CPS I and bovine OCT were injected intravenously into rats, the enzymes disappeared from blood roughly exponentially with apparent half-lives of about 67 and 18 min, respectively. Development of an ELISA for human CPS I and determination of the serum enzyme in various liver diseases remain to be performed.</p>","PeriodicalId":11854,"journal":{"name":"Enzyme & protein","volume":"48 4","pages":"213-21"},"PeriodicalIF":0.0000,"publicationDate":"1994-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000474991","citationCount":"17","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Enzyme & protein","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000474991","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 17

Abstract

Carbamoylphosphate synthetase I (CPS I), a urea cycle enzyme, is located almost exclusively in the mitochondria of hepatocytes. The enzyme is unique in that it constitutes about 2-6% of total liver protein and is composed of a large subunit of 160 kD. We developed a sensitive enzyme-linked immunosorbent assay (ELISA) for measurement of the enzyme in plasma using an antibody against the rat enzyme. In galactosamine-induced rat acute hepatitis, plasma concentration of CPS I that was 1-2 micrograms/ml blood before the treatment, increased up to 125 micrograms/ml blood in 24 h after the treatment and decreased to a near control level in 72 h. Plasma concentration of ornithine carbamoyl-transferase (OCT), another urea cycle enzyme, reached a maximum in 24 h and then decreased a little more rapidly than that of CPS I. On the other hand, alanine aminotransferase activity reached a maximum in 36 h and decreased to a normal level in 96 h. In immunoblot analysis, the native CPS I polypeptide of 160 kD and its fragments of 140 and 125 kD were detected 24-48 h after the treatment. When purified rat CPS I and bovine OCT were injected intravenously into rats, the enzymes disappeared from blood roughly exponentially with apparent half-lives of about 67 and 18 min, respectively. Development of an ELISA for human CPS I and determination of the serum enzyme in various liver diseases remain to be performed.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
大鼠实验性肝炎血浆酶甲氨甲酰磷酸合成酶ⅰ的酶联免疫吸附测定及其清除。
氨甲酰磷酸合成酶I (CPS I)是一种尿素循环酶,几乎只存在于肝细胞的线粒体中。该酶的独特之处在于,它占肝脏总蛋白的2-6%,由一个大的160 kD亚基组成。我们开发了一种灵敏的酶联免疫吸附试验(ELISA),用于使用针对大鼠酶的抗体来测量血浆中的酶。在半乳糖胺诱导的急性肝炎大鼠中,治疗前血浆中CPS I浓度为1 ~ 2微克/毫升血,治疗后24 h升高至125微克/毫升血,72 h降至接近对照水平。另一种尿素循环酶鸟氨酸氨基甲酰转移酶(OCT)在24 h达到最大值,随后下降速度略快于CPS I。丙氨酸转氨酶活性在36 h达到最大值,96 h降至正常水平。在免疫印迹分析中,在处理后24-48 h检测到160 kD的天然CPS I多肽及其140和125 kD的片段。将纯化的大鼠CPS I和牛OCT静脉注射到大鼠体内后,酶从血液中呈指数型消失,表观半衰期分别约为67 min和18 min。人类CPS I酶联免疫吸附试验的开发和各种肝脏疾病血清酶的测定仍有待进行。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells. What structure and function of avian plasminogen activator and matrix metalloproteinase-2 reveal about their counterpart mammalian enzymes, their regulation and their role in tumor invasion. Proteases associated with invadopodia, and their role in degradation of extracellular matrix. Cooperation between matrix metalloproteinases and the plasminogen activator-plasmin system in tumor progression. Urokinase plasminogen activator as a predictor of aggressive disease in breast cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1